<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p7" style="overflow: hidden; position: relative; background-color: white; width: 1210px; height: 935px;">
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<style type="text/css" >

#t1_7{left:285px;bottom:860px;letter-spacing:-0.32px;word-spacing:0.06px;}
#t2_7{left:285px;bottom:827px;letter-spacing:-0.27px;}
#t3_7{left:36px;bottom:25px;letter-spacing:0.07px;word-spacing:0.01px;}
#t4_7{left:341px;bottom:30px;}
#t5_7{left:348px;bottom:25px;letter-spacing:0.11px;}
#t6_7{left:377px;bottom:30px;}
#t7_7{left:381px;bottom:25px;letter-spacing:0.07px;word-spacing:-0.1px;}
#t8_7{left:540px;bottom:30px;}
#t9_7{left:546px;bottom:25px;letter-spacing:0.07px;}
#ta_7{left:996px;bottom:873px;letter-spacing:-0.1px;}
#tb_7{left:1043px;bottom:853px;letter-spacing:-0.22px;word-spacing:0.13px;}
#tc_7{left:1093px;bottom:833px;letter-spacing:-0.09px;}
#td_7{left:1091px;bottom:28px;letter-spacing:0.24px;}
#te_7{left:36px;bottom:778px;letter-spacing:-0.12px;word-spacing:0.02px;}
#tf_7{left:36px;bottom:748px;letter-spacing:-0.11px;}
#tg_7{left:36px;bottom:729px;letter-spacing:-0.09px;}
#th_7{left:41px;bottom:711px;}
#ti_7{left:58px;bottom:711px;letter-spacing:-0.09px;word-spacing:-0.11px;}
#tj_7{left:63px;bottom:693px;}
#tk_7{left:76px;bottom:693px;letter-spacing:-0.09px;}
#tl_7{left:63px;bottom:674px;}
#tm_7{left:76px;bottom:674px;letter-spacing:-0.09px;}
#tn_7{left:41px;bottom:656px;}
#to_7{left:58px;bottom:656px;letter-spacing:-0.09px;word-spacing:-0.23px;}
#tp_7{left:41px;bottom:638px;}
#tq_7{left:58px;bottom:638px;letter-spacing:-0.1px;}
#tr_7{left:63px;bottom:619px;}
#ts_7{left:76px;bottom:619px;letter-spacing:-0.09px;}
#tt_7{left:36px;bottom:601px;letter-spacing:-0.15px;word-spacing:0.06px;}
#tu_7{left:36px;bottom:583px;}
#tv_7{left:47px;bottom:583px;letter-spacing:-0.08px;word-spacing:-0.06px;}
#tw_7{left:47px;bottom:564px;letter-spacing:-0.09px;}
#tx_7{left:593px;bottom:564px;letter-spacing:-0.13px;}
#ty_7{left:627px;bottom:564px;letter-spacing:-0.08px;}
#tz_7{left:47px;bottom:546px;letter-spacing:-0.1px;word-spacing:0.01px;}
#t10_7{left:36px;bottom:528px;letter-spacing:-0.15px;word-spacing:0.06px;}
#t11_7{left:36px;bottom:509px;letter-spacing:-0.09px;}
#t12_7{left:36px;bottom:491px;letter-spacing:-0.09px;}
#t13_7{left:47px;bottom:473px;letter-spacing:-0.08px;}
#t14_7{left:36px;bottom:454px;letter-spacing:-0.08px;}
#t15_7{left:41px;bottom:436px;}
#t16_7{left:58px;bottom:436px;letter-spacing:-0.1px;word-spacing:0.01px;}
#t17_7{left:443px;bottom:436px;letter-spacing:-0.09px;}
#t18_7{left:646px;bottom:436px;letter-spacing:-0.08px;}
#t19_7{left:63px;bottom:418px;}
#t1a_7{left:77px;bottom:418px;letter-spacing:-0.11px;word-spacing:0.03px;}
#t1b_7{left:351px;bottom:418px;letter-spacing:-0.12px;word-spacing:0.04px;}
#t1c_7{left:63px;bottom:399px;}
#t1d_7{left:77px;bottom:399px;letter-spacing:-0.11px;word-spacing:0.03px;}
#t1e_7{left:345px;bottom:399px;letter-spacing:-0.16px;word-spacing:0.07px;}
#t1f_7{left:63px;bottom:381px;}
#t1g_7{left:77px;bottom:381px;letter-spacing:-0.09px;}
#t1h_7{left:460px;bottom:381px;letter-spacing:-0.15px;word-spacing:0.06px;}
#t1i_7{left:41px;bottom:363px;}
#t1j_7{left:58px;bottom:363px;letter-spacing:-0.09px;}
#t1k_7{left:63px;bottom:344px;}
#t1l_7{left:76px;bottom:344px;letter-spacing:-0.09px;}
#t1m_7{left:244px;bottom:344px;letter-spacing:-0.13px;word-spacing:0.05px;}
#t1n_7{left:395px;bottom:344px;}
#t1o_7{left:400px;bottom:344px;letter-spacing:-0.08px;}
#t1p_7{left:77px;bottom:326px;letter-spacing:-0.1px;}
#t1q_7{left:63px;bottom:308px;}
#t1r_7{left:76px;bottom:308px;letter-spacing:-0.09px;}
#t1s_7{left:244px;bottom:308px;letter-spacing:-0.13px;word-spacing:0.04px;}
#t1t_7{left:439px;bottom:308px;}
#t1u_7{left:449px;bottom:308px;letter-spacing:-0.09px;}
#t1v_7{left:63px;bottom:289px;}
#t1w_7{left:76px;bottom:289px;letter-spacing:-0.09px;}
#t1x_7{left:244px;bottom:289px;letter-spacing:-0.14px;word-spacing:0.06px;}
#t1y_7{left:390px;bottom:289px;}
#t1z_7{left:401px;bottom:289px;letter-spacing:-0.08px;}
#t20_7{left:77px;bottom:271px;letter-spacing:-0.09px;}
#t21_7{left:63px;bottom:253px;}
#t22_7{left:76px;bottom:253px;letter-spacing:-0.09px;}
#t23_7{left:243px;bottom:253px;letter-spacing:-0.09px;}
#t24_7{left:481px;bottom:253px;letter-spacing:-0.08px;}
#t25_7{left:567px;bottom:253px;letter-spacing:-0.08px;}
#t26_7{left:36px;bottom:234px;letter-spacing:-0.15px;word-spacing:0.06px;}
#t27_7{left:36px;bottom:216px;}
#t28_7{left:47px;bottom:216px;letter-spacing:-0.08px;}
#t29_7{left:312px;bottom:216px;letter-spacing:-0.08px;}
#t2a_7{left:482px;bottom:216px;letter-spacing:-0.07px;}
#t2b_7{left:531px;bottom:216px;letter-spacing:-0.08px;}
#t2c_7{left:47px;bottom:198px;letter-spacing:-0.09px;}
#t2d_7{left:1091px;bottom:61px;letter-spacing:-0.11px;}
#t2e_7{left:23px;bottom:915px;letter-spacing:-0.14px;}

.s0_7{font-size:28px;font-family:Arial-BoldMT_5te;color:#000;}
.s1_7{font-size:9px;font-family:ArialMT_5tg;color:#000;}
.s2_7{font-size:5px;font-family:ArialMT_5tg;color:#000;}
.s3_7{font-size:17px;font-family:ArialMT_5tg;color:#0065A4;}
.s4_7{font-size:17px;font-family:Arial-BoldMT_5te;color:#000;}
.s5_7{font-size:17px;font-family:Arial-BoldMT_5te;color:#0065A4;}
.s6_7{font-size:17px;font-family:ArialMT_5tg;color:#000;}
.s7_7{font-size:17px;font-family:Webdings_k6;color:#000;}
.s8_7{font-size:17px;font-family:ArialMT_k0;color:#000;}
.s9_7{font-size:17px;font-family:SymbolMT_ka;color:#000;}
.sa_7{font-size:17px;font-family:Arial-ItalicMT_kb;color:#000;}
.sb_7{font-size:11px;font-family:Helvetica, Arial, sans-serif;color:#000;}
</style>
<style id="fonts7" type="text/css" >

@font-face {
	font-family: Arial-BoldMT_5te;
	src: url("fonts/Arial-BoldMT_5te.woff") format("woff");
}

@font-face {
	font-family: Arial-ItalicMT_kb;
	src: url("fonts/Arial-ItalicMT_kb.woff") format("woff");
}

@font-face {
	font-family: ArialMT_5tg;
	src: url("fonts/ArialMT_5tg.woff") format("woff");
}

@font-face {
	font-family: ArialMT_k0;
	src: url("fonts/ArialMT_k0.woff") format("woff");
}

@font-face {
	font-family: SymbolMT_ka;
	src: url("fonts/SymbolMT_ka.woff") format("woff");
}

@font-face {
	font-family: Webdings_k6;
	src: url("fonts/Webdings_k6.woff") format("woff");
}

</style>
<div id="pg7Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg7" style="-webkit-user-select: none;"><object width="1210" height="935" data="7/7.svg" type="image/svg+xml" id="pdf7" style="width:1210px; height:935px; z-index: 0;"></object></div>
<div class="text-container"><span id="t1_7" class="t s0_7">NCCN Guidelines Version 4.2024 </span>
<span id="t2_7" class="t s0_7">Head and Neck Cancers </span>
<span id="t3_7" class="t s1_7">Version 4.2024, 5/1/2024 © 2024 National Comprehensive Cancer Network </span>
<span id="t4_7" class="t s2_7">® </span>
<span id="t5_7" class="t s1_7">(NCCN </span>
<span id="t6_7" class="t s2_7">® </span>
<span id="t7_7" class="t s1_7">), All rights reserved. NCCN Guidelines </span>
<span id="t8_7" class="t s2_7">® </span>
<span id="t9_7" class="t s1_7">and this illustration may not be reproduced in any form without the express written permission of NCCN. </span>
<span id="ta_7" class="t s3_7">NCCN Guidelines Index </span>
<span id="tb_7" class="t s3_7">Table of Contents </span>
<span id="tc_7" class="t s3_7">Discussion </span>
<span id="td_7" class="t s4_7">UPDATES </span>
<span id="te_7" class="t s4_7">Updates in Version 1.2024 of the NCCN Guidelines for Head and Neck Cancers from Version 2.2023 include: </span>
<span id="tf_7" class="t s5_7">SALI-B </span>
<span id="tg_7" class="t s6_7">• Useful in Certain Circumstances </span>
<span id="th_7" class="t s7_7"></span><span id="ti_7" class="t s8_7">Androgen receptor (AR) therapy for AR+ tumors, regimens added: </span>
<span id="tj_7" class="t s9_7">◊ </span><span id="tk_7" class="t s6_7">Abiraterone </span>
<span id="tl_7" class="t s9_7">◊ </span><span id="tm_7" class="t s6_7">Goserelin (category 2B) </span>
<span id="tn_7" class="t s7_7"></span><span id="to_7" class="t s8_7">Regimen added: Axitinib + avelumab for ACC (category 2B) </span>
<span id="tp_7" class="t s7_7"></span><span id="tq_7" class="t s8_7" data-mappings='[[12,"fi"]]'>Regimen modiﬁed: </span>
<span id="tr_7" class="t s9_7">◊ </span><span id="ts_7" class="t s8_7">Fam-trastuzumab deruxtecan-nxki: Category of evidence changed from 2B to 2A. </span>
<span id="tt_7" class="t s5_7">FOLL-A (1 of 2) </span>
<span id="tu_7" class="t s6_7">• </span><span id="tv_7" class="t s8_7" data-mappings='[[13,"fi"]]'>Bullet 2 modiﬁed: AM cortisol, growth hormone (GH), free T4, prolactin, insulin-like growth factor 2 (IGF-2), luteinizing hormone (LH), follicle- </span>
<span id="tw_7" class="t s6_7">stimulating hormone (FSH), serum adrenocorticotropic hormone (ACTH), </span><span id="tx_7" class="t sa_7">TSH</span><span id="ty_7" class="t s6_7">, and total and bioavailable testosterone levels annually to evaluate </span>
<span id="tz_7" class="t s6_7">panhypopituitarism following RT to the skull basec (category 2B) </span>
<span id="t10_7" class="t s5_7">IMG-A (1 of 4) </span>
<span id="t11_7" class="t s6_7">• Bullet removed: Imaging is done with contrast, unless contraindicated. </span>
<span id="t12_7" class="t s6_7">• Bullet added: CT is performed with contrast. CT imaging of the chest can be performed with or without contrast, as clinically indicated. MRI is performed </span>
<span id="t13_7" class="t s6_7">with and without contrast, unless contraindicated. </span>
<span id="t14_7" class="t s6_7">• Initial workup, bullet 1: </span>
<span id="t15_7" class="t s7_7"></span><span id="t16_7" class="t s8_7" data-mappings='[[17,"fi"]]'>Sub-bullet 2 modiﬁed: CT is complementary to MRI </span><span id="t17_7" class="t sa_7">for head and neck cancers </span><span id="t18_7" class="t s6_7">for the following conditions: </span>
<span id="t19_7" class="t s9_7">◊ </span><span id="t1a_7" class="t s6_7">Sub-sub-bullet 1: Oral cavity cancer, </span><span id="t1b_7" class="t s6_7">To evaluate cortical bone erosion or periosteal invasion </span>
<span id="t1c_7" class="t s9_7">◊ </span><span id="t1d_7" class="t s6_7">Sub-sub-bullet 2: Laryngeal cancer, </span><span id="t1e_7" class="t s6_7">To evaluate cartilage invasion </span>
<span id="t1f_7" class="t s9_7">◊ </span><span id="t1g_7" class="t s6_7">Sub-sub-bullet 3: Sinonasal and skull base lesions, </span><span id="t1h_7" class="t s6_7">To evaluate bony erosion/destruction </span>
<span id="t1i_7" class="t s7_7"></span><span id="t1j_7" class="t s6_7">Sub-bullet 3 </span>
<span id="t1k_7" class="t s9_7">◊ </span><span id="t1l_7" class="t s8_7" data-mappings='[[17,"fi"]]'>Sub-bullet 1 modiﬁed: </span><span id="t1m_7" class="t s6_7">Oral cavity cancer, i </span><span id="t1n_7" class="t sa_7">I</span><span id="t1o_7" class="t s6_7">f there is a need to evaluate the extent of bone marrow invasion or in patients with extensive dental </span>
<span id="t1p_7" class="t s6_7">amalgam that may obscure the anatomy on CT </span>
<span id="t1q_7" class="t s9_7">◊ </span><span id="t1r_7" class="t s8_7" data-mappings='[[17,"fi"]]'>Sub-bullet 2 modiﬁed: </span><span id="t1s_7" class="t s6_7">Nasopharyngeal cancer, t </span><span id="t1t_7" class="t sa_7">T</span><span id="t1u_7" class="t s6_7">o assess skull base invasion and cranial nerve involvement </span>
<span id="t1v_7" class="t s9_7">◊ </span><span id="t1w_7" class="t s8_7" data-mappings='[[17,"fi"]]'>Sub-bullet 3 modiﬁed: </span><span id="t1x_7" class="t s6_7">Sinonasal cancer, t </span><span id="t1y_7" class="t sa_7">T</span><span id="t1z_7" class="t s8_7" data-mappings='[[68,"ff"]]'>o evaluate skull base or intracranial or orbital invasion, and to diﬀerentiate tumor from obstructed </span>
<span id="t20_7" class="t s6_7">sinuses </span>
<span id="t21_7" class="t s9_7">◊ </span><span id="t22_7" class="t s8_7" data-mappings='[[17,"fi"]]'>Sub-bullet 4 modiﬁed: </span><span id="t23_7" class="t s6_7">Any head and neck cancer with </span><span id="t24_7" class="t sa_7">If there are </span><span id="t25_7" class="t s6_7">cranial nerve symptoms or if radiographic perineural tumor spread is a possibility </span>
<span id="t26_7" class="t s5_7">IMG-A (4 of 4) </span>
<span id="t27_7" class="t s6_7">• </span><span id="t28_7" class="t s8_7" data-mappings='[[13,"fi"]]'>Bullet 5 modiﬁed: US of the neck is </span><span id="t29_7" class="t sa_7">a well-established tool </span><span id="t2a_7" class="t s6_7">useful </span><span id="t2b_7" class="t s6_7">for nodal surveillance. US is generally widely available, safe, fast, inexpensive, and an </span>
<span id="t2c_7" class="t s6_7">accurate modality for examination of the neck for any suspicious nodal disease. </span>
<span id="t2d_7" class="t s5_7">Continued </span>
<span id="t2e_7" class="t sb_7">Printed by Fredd Merc on 8/29/2024 4:45:54 AM. For personal use only. Not approved for distribution. Copyright © 2024 National Comprehensive Cancer Network, Inc., All Rights Reserved. </span></div>

</div>
</body>
</html>
